New research will improve safety and quality of heparin

New research will improve safety and quality of heparin

A new method to analyze the blood thinning drug heparin has been developed that can pinpoint contaminants more accurately and quickly, providing greater quality control and safety.

Comments are closed.

AstraZeneca vaccine and Guillain-Barré syndrome: There’s minimal cause for concern
14 May 2021
Herd immunity appears unlikely for COVID-19, but CDC says vaccinated people can ditch masks in most settings
14 May 2021